pyrroles has been researched along with Mast-Cell Sarcoma in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Best, MP; Boyd, SP; Danesi, P | 1 |
Charles, JB; Ehrhart, EJ; Thamm, DH; Weishaar, KM | 1 |
Baumgartner, S; Cerny-Reiterer, S; Eisenwort, G; Gleixner, KV; Hadzijusufovic, E; Hoermann, G; Kundi, M; Mayerhofer, M; Peter, B; Pickl, WF; Schuch, K; Sperr, WR; Stefanzl, G; Valent, P; Willmann, M | 1 |
Gordon, I; Khanna, C | 1 |
Bergman, PJ; Boucher, JF; Couto, GC; Henry, CJ; Hintermeister, JG; Klein, MK; London, CA; Malpas, PB; Mauldin, GN; Michels, GM; Mitchener, KL; Rosenberg, MP; Rusk, AW; Wood-Follis, SL | 1 |
Kupfer, J | 1 |
Airley, R | 1 |
Cherrington, JM; Lee, LB; London, CA; Pryer, NK; Sukbuntherng, J; Yu, X; Zadovaskaya, R | 1 |
Cherrington, JM; Chien, MB; Liao, AT; London, CA; McMahon, G; Mendel, DB; Shenoy, N | 1 |
Basel, CT | 1 |
1 review(s) available for pyrroles and Mast-Cell Sarcoma
Article | Year |
---|---|
The antibiotic complex of the verrucarins and roridins.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Benzopyrans; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Chick Embryo; Dogs; Haplorhini; Lactones; Lethal Dose 50; Mast-Cell Sarcoma; Mice; Microbial Sensitivity Tests; Oxepins; Pyrroles; Rats; Sarcoma, Experimental; Sarcoma, Yoshida; Sesquiterpenes; Sterols; Structure-Activity Relationship | 1974 |
1 trial(s) available for pyrroles and Mast-Cell Sarcoma
Article | Year |
---|---|
Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Gene Expression Regulation, Neoplastic; Indoles; Mast-Cell Sarcoma; Phosphorylation; Prospective Studies; Proto-Oncogene Proteins c-kit; Pyrroles; Skin Neoplasms; Vinblastine | 2020 |
8 other study(ies) available for pyrroles and Mast-Cell Sarcoma
Article | Year |
---|---|
Confirmed case of Pneumocystis pneumonia in a Maltese Terrier × Papillon dog being treated with toceranib phosphate.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Female; Indoles; Mast-Cell Sarcoma; Pneumonia, Pneumocystis; Pyrroles; Sulfadoxine; Treatment Outcome; Trimethoprim | 2019 |
The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Mast-Cell Sarcoma; Membrane Proteins; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrroles; RNA, Messenger | 2014 |
Catching cancer by the tail: new perspectives on the use of kinase inhibitors.
Topics: Animals; Dog Diseases; Dogs; Indoles; Mast-Cell Sarcoma; Neoplasm Recurrence, Local; Pyrroles; Random Allocation; Receptor Protein-Tyrosine Kinases; Treatment Outcome | 2009 |
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
Topics: Animals; Anorexia; Diarrhea; Disease Progression; Dog Diseases; Dogs; Female; Indoles; Male; Mast-Cell Sarcoma; Neoplasm Recurrence, Local; Pyrroles; Random Allocation; Receptor Protein-Tyrosine Kinases; Treatment Outcome; Vomiting | 2009 |
Cutaneous mast cell tumours in dogs.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Indoles; Mast-Cell Sarcoma; Pyrroles; Research; Skin Neoplasms | 2010 |
Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers?
Topics: Animals; Antineoplastic Agents; Benzamides; Breast Neoplasms; Cats; Disease Models, Animal; Dogs; Female; Humans; Imatinib Mesylate; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mast-Cell Sarcoma; Neoplasms; Piperazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Thiazoles; Transcriptome | 2012 |
Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
Topics: Animals; Dog Diseases; Dogs; Enzyme Inhibitors; Indoles; Mast Cells; Mast-Cell Sarcoma; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Phosphorylation; Proto-Oncogene Proteins c-kit; Pyrroles; Recurrence | 2003 |
Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Indoles; Mast-Cell Sarcoma; Mutation; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrroles; Tumor Cells, Cultured | 2002 |